International Journal of Oncology · 2013 · 34 citations · 28 references
MedicineMolecular BiologyOncologyMetastasisMolecular OncologyTumor ProgressionAndrogen Deprivation TherapyAndrogen PhysiologyHormonal Cancer TherapyHormonal TherapyProstate CancerSteroid Hormone SignalingCalpain ActivityCalpain SystemCalpain-mediated ProteolysisContinuous Androgen Deprivation TherapyHormone-dependent Prostate CancerMetastatic MechanismsMetastatic NeoplasiaProstate Cancer Hormonal Therapy
Understanding the molecular mechanism of prostate cancer progression from androgen dependence to independence may lead to developing more effective treatments against prostate cancer. Herein, our previous in vitro model was employed to assess the effects of continuous androgen-deprivation on developing the metastatic phenotype from androgen-dependent prostate cancer cells (LNCaP). The results indicated that long-term androgen deprivation resulted in overexpression of calpain 2 and increased expression of filamin A (FlnA), but not for calpain 1. The enhanced activity of calpain 2 was confirmed by the accumulation of cleaved FlnA fragments, which could be effectively blocked by calpeptin (an inhibitor of calpain 2). Therefore, the combination of calpain 2 inhibitor and androgen deprivation may provide new therapeutic strategy for patients to prevent or postpone prostate cancer progression.
28
Philip A. Watson, Yinan F. Chen, Minna Balbas et al. · Proceedings of the National Academy of Sciences · 2010 · 637 citations · Full text
Calpain-mediated proteolysis of talin regulates adhesion dynamics
Santos J. Franco, Mary A. Rodgers, Benjamin J. Perrin et al. · Nature Cell Biology · 2004 · 553 citations
A Gain-of-Function Mutation in DHT Synthesis in Castration-Resistant Prostate Cancer
Kai‐Hsiung Chang, Rui Li, Barbara Kuri et al. · Cell · 2013 · 313 citations · Full text
Evolution of the Androgen Receptor Pathway during Progression of Prostate Cancer
Peter J.M. Hendriksen, Natasja F. Dits, Koichi Kokame et al. · Cancer Research · 2006 · 230 citations
Medicine, Endocrinology, Oncology +11